Zhejiang Tailin BioEngineeringLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Da Lin Ye
Chief executive officer
CN¥606.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 52.1% |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You
Oct 08
Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up
May 09Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up
Mar 08CEO
Da Lin Ye (64 yo)
no data
Tenure
CN¥606,500
Compensation
Mr. Da Lin Ye serves as Chairman and General Manager at Zhejiang Tailin BioEngineering Co.,Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | no data | CN¥606.50k | 52.07% CN¥ 1.1b | |
| Deputy GM & Director | no data | CN¥1.15m | 0.82% CN¥ 16.6m | |
| Deputy GM & Director | no data | CN¥1.18m | 1.05% CN¥ 21.3m | |
| Director | no data | no data | 5.68% CN¥ 114.8m | |
| Manager of Analytical Instruments Business Department & Member of Supervisory Board | no data | CN¥315.60k | no data | |
| Manager of Life Science Research & Development & Employee Representative to the Supervisory Board | no data | CN¥222.30k | no data | |
| Chairman of the Supervisory Board & GM of Business Unit | 3.8yrs | CN¥257.60k | no data | |
| Independent Director | 4.6yrs | CN¥80.00k | no data | |
| Independent Director | 5.5yrs | CN¥80.00k | no data | |
| Independent Director | 1.7yrs | CN¥60.00k | no data | |
| Non-Employee Supervisor | less than a year | no data | no data |
3.8yrs
Average Tenure
60yo
Average Age
Experienced Board: 300813's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 11:53 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Tailin BioEngineering Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|